User:Goorgle/Books/Pharmacology Wiki 101
 | The Wikimedia Foundation's book rendering service has been withdrawn. Please upload your Wikipedia book to one of the external rendering services. |
 | You can still create and edit a book design using the Book Creator and upload it to an external rendering service:
|
| This user book is a user-generated collection of Wikipedia articles that can be easily saved, rendered electronically, and ordered as a printed book. If you are the creator of this book and need help, see Help:Books (general tips) and WikiProject Wikipedia-Books (questions and assistance). Edit this book: Book Creator · Wikitext Order a printed copy from: PediaPress [ About ] [ Advanced ] [ FAQ ] [ Feedback ] [ Help ] [ WikiProject ] [ Recent Changes ] | ||||||||
Pharmacology Wiki 101[edit]
Pharmacology Wiki 101[edit]
- 2,4-Dinitrophenol
- 2-Arachidonoylglycerol
- 4-Nitroquinoline 1-oxide
- 5-HT2c receptor agonist
- 5-HT2C receptor agonists
- Acemannan
- Active ingredient
- Active metabolite
- Addiction medicine
- Adipotide
- Adrenergic
- Adrenorphin
- Adverse drug reaction
- Adverse effect
- Agonist
- Agonist–antagonist
- Alcohol withdrawal syndrome
- Allosteric modulator
- Amfecloral
- Amidorphin
- Amino acid neurotransmitter
- Anabolic steroid
- Anandamide
- Anatomical Therapeutic Chemical Classification System
- Anavex Life Sciences
- Anesthetic
- Anorectic
- Antacid
- Anti-inflammatory
- Anti-obesity medication
- Anticoagulant
- Antidepressant
- Antimicrobial pharmacodynamics
- Antimigraine
- Antimony pill
- Antisialagogue
- Antitarget
- Antithyroid agent
- Applicability domain
- Aspartic acid
- Association for Ocular Pharmacology and Therapeutics
- Asuragen
- Augmentation (psychiatry)
- Australian Medicines Handbook
- Australian Pharmaceutical Formulary
- Autopharmacology
- Azalanstat
- Baseline (pharmacology)
- Beloranib
- Benfluorex
- Benzodiazepine
- Benzodiazepine dependence
- Benzodiazepine withdrawal syndrome
- Benzphetamine
- Bernice Eddy
- Beta-endorphin
- Binding coefficient
- Binding selectivity
- Bioassay
- Biologic medical product
- Biological activity
- Biological target
- Biopharmaceutics Classification System
- Biopharmacology
- Biotechnology in pharmaceutical manufacturing
- Black triangle (pharmacovigilance)
- Blind experiment
- Blood/gas partition coefficient
- Body surface area
- Bolus (medicine)
- British Approved Name
- British National Formulary for Children
- British Pharmaceutical Codex
- British Pharmacopoeia
- Bupropion/naltrexone
- Bupropion/zonisamide
- Burow's solution
- Cancer Trials Support Unit
- Catecholamine
- Ceiling effect (pharmacology)
- Central Drugs Standard Control Organization
- Certain safety factor
- Cetilistat
- Channel blocker
- Channel opener
- Chemogenomics
- Chemotactic drug-targeting
- Chemotherapy-induced acral erythema
- Chinese Medical Herbology and Pharmacology
- Cholinergic crisis
- Christophe Wiart
- Clark's rule
- Classical pharmacology
- Classification of Pharmaco-Therapeutic Referrals
- Clearance (medicine)
- Clinical investigator
- Clinical neurochemistry
- Clinical pharmacology
- Clinical trial
- Clinical trials unit
- Combination drug
- Combination therapy
- Combined drug intoxication
- Compendium of Materia Medica
- Competitive antagonist
- Compliance (medicine)
- Compound spirit of ether
- Compounding
- Concord Prison Experiment
- Conditioned place preference
- Context-sensitive half-life
- Cooperstown cocktail
- Corticosteroid
- Cosmetic pharmacology
- COSTART
- Counterirritant
- Course (medicine)
- Cross-tolerance
- Crossover study
- Cytel
- Cytoprotection
- Delayed release
- Deliriant
- Dermal patch
- Desensitization (medicine)
- Desmoteplase
- Detoxication
- Dexfenfluramine
- Dilution assay
- Dirlotapide
- Discovery and development of mTOR inhibitors
- Discovery and development of thalidomide and its analogs
- Dissociative
- Distribution (pharmacology)
- Dixanthogen
- Dopamine
- Dopaminergic
- Dosage form
- Dose (biochemistry)
- Dose concentration
- Dose–response relationship
- Dosing
- Drug action
- Drug coupon
- Drug design
- Drug development
- Drug discovery
- Drug eruption
- Drug holiday
- Drug Identification Number
- Drug interaction
- Drug intolerance
- Drug metabolism
- Drug nomenclature
- Drug reaction testing
- Drug repositioning
- Drug resistance
- Drug tolerance
- Druglikeness
- Drugs in pregnancy
- Dynorphin
- Eagle effect
- EC50
- Effective dose (pharmacology)
- Effective half-life
- Effects of long-term benzodiazepine use
- Effervescent tablet
- Eledoisin
- Elimination (pharmacology)
- Empathogen-entactogen
- Endogenous agonist
- Endorphins
- Endozepine
- Enteric coating
- Environmental impact of pharmaceuticals and personal care products
- Epinephrine
- EPPTB
- Epratuzumab
- Equianalgesic
- Equipotent molar ratio
- Ethnopsychopharmacology
- Eudysmic ratio
- Euphoriant
- European Pharmacopoeia
- Excipient
- Expanded access
- Experimental drug
- False neurotransmitter
- Farmacotherapeutisch Kompas
- Federation of European Pharmacological Societies
- Fenbutrazate
- FIASMA
- Fine chemical
- First-dose phenomenon
- FMRFamide
- Food and Drug Administration
- Forced diuresis
- Formulary (pharmacy)
- Formulation
- Functional selectivity
- GABA antagonist
- GABAA receptor positive allosteric modulators
- Galactagogue
- Gamma-Aminobutyric acid
- Gamma-Hydroxybutyric acid
- Gasotransmitter
- Gastrin-releasing peptide
- General anaesthetic
- Generic Product Identifier
- Gerald Muench
- Gliotransmitter
- Glucuronide
- Glutamate carboxypeptidase II
- Glutamate receptor
- Glutamic acid
- Glycerite
- Glycine
- Goodman & Gilman's The Pharmacological Basis of Therapeutics
- Grapefruit–drug interactions
- GS-39783
- Gu (poison)
- Guide to Pharmacology
- Hazardous drugs
- HERG
- Heteromer
- Histamine
- History of catecholamine research
- History of pharmacy
- Hit to lead
- HIV drug resistance
- Hormonal therapy (oncology)
- HTR3A
- HTR3B
- HTR3C
- HTR3D
- HTR3E
- Hy's law
- HYDIA
- Hypnotic
- IC50
- Idiosyncratic drug reaction
- IdMOC
- Indian Pharmacopoeia Commission
- Indirect agonist
- Indolamines
- Influenza Antiviral Drug Search
- Injection (medicine)
- Institutional review board
- Interaction
- International Cannabinoid Research Society
- International Nonproprietary Name
- International Psychopharmacology Algorithm Project
- International unit
- Intrinsic activity
- Inverse agonist
- Ion trapping
- IUPHAR Database
- Japanese Approved Name
- Japanese Pharmacopoeia
- Kindling (sedative-hypnotic withdrawal)
- King's American Dispensatory
- Krzysztof Palczewski
- Laxative
- Lemont Kier
- Leukemia inhibitory factor
- Li Shizhen
- Liberation (pharmacology)
- Lipinski's rule of five
- Lipophilic efficiency
- List of drug interactions
- List of pharmaceutical compound number prefixes
- Loading dose
- Local anesthetic
- Loewe additivity
- Maintenance dose
- Malotilate
- Martindale: The Complete Drug Reference
- Materia medica
- Mayamycin
- Mechanism of action
- MedDRA
- Median toxic dose
- Medical prescription
- Medicina Plinii
- Medicinal product
- Medicine
- Melafix
- MGS-0039
- Microdispensing
- Miodrag Radulovacki
- Monastrol
- Monoamine neurotransmitter
- Monotherapy
- Most probable number
- Multidrug-resistant gram-negative bacteria
- Multiple drug resistance
- Murphy drip
- Muscle relaxant
- N-Methyl-D-aspartic acid
- Named patient programs
- NAMI-A
- Nasal spray
- National Agency for Food and Drug Administration and Control
- National Drug Code
- National Drug Code System
- National Medicinal Drugs Policy
- National Pharmaceutical Product Index
- National pharmaceuticals policy
- Neoendorphin
- Neural drug delivery systems
- Neuropharmacology
- Neuropharmacology (journal)
- Neuropsychopharmacology
- Neurotoxin
- Neurotransmitter
- Nitric oxide
- Nocebo
- Non-competitive inhibition
- Non-noradrenergic, non-cholinergic transmitter
- Norepinephrine
- Norfenefrine
- Number needed to harm
- Number needed to treat
- Ocriplasmin
- Oculomucocutaneous syndrome
- Off-label use
- Officinal
- Oleoylethanolamide
- Olesoxime
- Onset of action
- Open channel block
- Open-label trial
- Optimal biological dose
- Oral administration
- Oral sedation dentistry
- Oralin (insulin)
- Osmotic diuretic
- OSU-6162
- Oxygen diffusion-enhancing compound
- Oxytocin
- Oxytrex
- Paradoxical disinhibition
- Paradoxical reaction
- Partial agonist
- PDE5 drug design
- Penicillin drug reaction
- Personalized medicine
- Peter Rheinstein
- Pharma fraud
- Pharmaceutic adjuvant
- Pharmaceutical code
- Pharmaceutical drug
- Pharmaceutical glaze
- Pharmaceutical industry
- Pharmaceutical ink
- Pharmaceutical medicine
- Pharmaceutical Press
- Pharmaceutical sciences
- Pharmacodynamics
- Pharmacoeconomics
- Pharmacoepidemiology
- Pharmacogenetics
- Pharmacogenomics
- Pharmacognosy
- Pharmacoinformatics
- Pharmacokinetics
- Pharmacological Calvinism
- Pharmacological chaperone
- Pharmacological gene therapy
- Pharmacology
- Pharmacometrics
- Pharmacon
- Pharmaconomist
- Pharmaconomy
- Pharmacophore discovery
- Pharmacopoeia
- Pharmacopoeia of the People's Republic of China
- Pharmacotherapy
- Pharmacotoxicology
- Pharmacovigilance
- Pharmacy
- Pharming (genetics)
- Phasic transmitter
- Phonophoresis
- Phospholipidosis
- Photosensitivity
- Physiological agonism and antagonism
- Physiologically based pharmacokinetic modelling
- Phytopharmacology
- Pill dispenser
- Pill organizer
- PK/PD models
- Placebo
- Placebo-controlled study
- Plateau principle
- Pleiotropy (drugs)
- Polymersome
- Polypharmacy
- Polysubstance dependence
- Porous silicon
- Positional alcohol nystagmus
- Postmarketing surveillance
- Potency (pharmacology)
- PPAR agonist
- Pregnancy category
- Prescription cascade
- Prescription costs
- Prescription drug
- Prescriptive authority for psychologists movement
- Proctosedyl
- Prodrug
- Prodynorphin
- Professional Further Education in Clinical Pharmacy and Public Health
- Prostaglandin analogue
- Protective index
- Provocation test
- Psychiatric medication
- Psychopharmacology
- Psychotomimetic
- PTC Therapeutics
- Qualified Person for Pharmacovigilance
- Quantitative pharmacology
- Quantitative structure–activity relationship
- Rate of infusion
- Rebound effect
- Receptor antagonist
- Releasing agent
- Research chemical
- Research on Adverse Drug Events and Reports
- Retrometabolic drug design
- Reuptake
- Reuptake inhibitor
- Reverse pharmacology
- Reward dependence
- Ritalin class action lawsuits
- Robertson Centre for Biostatistics
- Route of administration
- Safety pharmacology
- Schild regression
- Sedative
- Selective receptor modulator
- Sepiapterin reductase deficiency
- Serotonergic
- Serotonin
- Serotonin pathways
- Serotonin syndrome
- Side effect
- Sodium ferric gluconate complex
- Source document
- Specol
- Statisticians in the Pharmaceutical Industry
- Stearoylethanolamide
- Structured intermittent therapy
- Subcutaneous injection
- Substance P
- Summary of Product Characteristics
- Suspected Adverse Reaction Surveillance Scheme
- Syed Ziaur Rahman
- Synaptic pharmacology
- Systems pharmacology
- TA-CD
- TA-NIC
- Table of volume of distribution for drugs
- Tablet (pharmacy)
- Tablet hardness testing
- Tachykinin peptides
- Tachyphylaxis
- Tasquinimod
- Tetrachlorodecaoxide
- The International Pharmacopoeia
- The Pharma Letter
- Therapeutic effect
- Therapeutic index
- Therapeutic Targets Database
- Therapeutic window
- Therapy
- Thyroid hormone
- Time release technology
- Timeline of antibiotics
- Toba medicine container
- Tolerability
- Toxication
- Toxicodynamics
- Trace amine
- Transdermal patch
- Trough level
- Ukrainian Pharmacy Holding
- Uncoupling (neuropsychopharmacology)
- Unique Ingredient Identifier
- United States Adopted Name
- United States Pharmacopeia
- Uppsala Monitoring Centre
- USP Dissolution Apparatus 2
- Vasopressin analogue
- Volume of distribution
- WHO Drug Dictionary
- WHOART
- William E. Evans (pharmacist)
- Zoopharmacognosy